Clover Health posts $6M Q3 net income, upgrades 2026 guidance with strong Medicare Advantage growth

Clover Health reported a $6 million GAAP net income for Q3 2026, a $31 million improvement year-over-year, driven by a 45% increase in Medicare Advantage membership and 53% revenue growth. The company raised its full-year 2026 guidance, expecting 47% membership growth, $2.97-$3.00 billion in revenues, and $25-$35 million in net income. Clover’s flagship PPO plan earned a 5 Star rating for 2028, supporting strong market positioning and anticipated earnings growth in 2027. Management highlighted the impact of their technology platform, Clover Assistant, in improving care quality and cost management.

Clover Health's stock price surged 8.86% to USD 4.67 on Pluang as of Nov 05, 2026 04:24 WIB, reflecting strong investor interest following the company's positive Q3 results and raised full-year guidance. The stock trades with a market cap of $2.28 billion and a 52-week high of $5.41, indicating significant growth potential. This price movement aligns with Clover's reported 53% revenue growth and a 45% increase in Medicare Advantage membership, underscoring optimism about its future performance.